What's breaking now, across thousands of outlets.
(RTTNews) - Jade Biosciences, Inc. (JBIO) announced preclinical data for JADE301, an investigational, anti-IFN-Beta monoclonal antibody being developed for dermatomyositis, a rare autoimmune disease that can cause skin inflammation and muscle weakness.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The Accra Metropolitan Assembly (AMA) has directed shops, markets, and other commercial establishments within its jurisdiction to suspend operations from 6:00 a.m. to 12:00 p.m.
Dell Technologies can become a multibagger over the next three years.
There are a variety of injuries that will impact fantasy football in Week 4. Here’s how fantasy managers can adjust to win their matchups.
Stock-market risks are everywhere. But you’d be hard pressed to tell anything was wrong by looking at the surface of major US equity gauges.
The Cape Coral, Florida-based company provides aftermarket services and parts for steam and gas turbines in the power generation, industrial and petrochemical markets.
Key drivers for the common currency will be expectations for Fed and ECB policy
